Evaluation of survivin immunoexpression in the differentiation of high- and low-grade breast ductal carcinoma in situ. [electronic resource]
- Einstein (Sao Paulo, Brazil) 2018
- eAO4065 p. digital
Publication Type: Journal Article
2317-6385
10.1590/s1679-45082018ao4065 doi
Biomarkers, Tumor--metabolism Breast Neoplasms--metabolism Carcinoma in Situ--metabolism Carcinoma, Ductal, Breast--metabolism Female Humans Immunohistochemistry Inhibitor of Apoptosis Proteins--metabolism Survivin